Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 YearWalter Reinisch, Lakshmi Padgett, Judith Collins et al.|Clinical and Translational Gastroenterology|2016Cited by 40
Clinical Outcomes in Continuous Clinical Responders with Moderately to Severely Active Ulcerative Colitis: Subanalyses from the PURSUIT-SC Maintenance StudyWilliam J. Sandborn, Paul Rutgeerts, Jean–Frédéric Colombel et al.|The American Journal of Gastroenterology|2014Cited by 2
Assessment of Fecal Markers and Clinical Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results from PURSUIT-SC InductionWilliam J. Sandborn, Paul Rutgeerts, Brian G. Feagan et al.|The American Journal of Gastroenterology|2014Cited by 0